Source:http://linkedlifedata.com/resource/pubmed/id/11089665
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2001-2-23
|
pubmed:abstractText |
Routine use of mupirocin to prevent staphylococcal infections is controversial. We assessed attitudes and practices of healthcare professionals attending the Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections regarding mupirocin prophylaxis. Eighty percent of participants did not use mupirocin routinely. At the end of the session, 58% indicated they would consider increased use of mupirocin.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0899-823X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
745-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11089665-Anti-Bacterial Agents,
pubmed-meshheading:11089665-Attitude of Health Personnel,
pubmed-meshheading:11089665-Cross Infection,
pubmed-meshheading:11089665-Humans,
pubmed-meshheading:11089665-Mupirocin,
pubmed-meshheading:11089665-Staphylococcal Infections,
pubmed-meshheading:11089665-Staphylococcus aureus
|
pubmed:year |
2000
|
pubmed:articleTitle |
Should we routinely use mupirocin to prevent staphylococcal infections?
|
pubmed:affiliation |
Division of Applied Public Health Training, Epidemiology Program Office, Centers for Disease Control and Prevention, Public Health Service, United States Department of Health and Human Services, Atlanta, Georgia, USA.
|
pubmed:publicationType |
Journal Article
|